Search research articles
Contact Us
Filters
Showing results (41-50 of 70) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2003
Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2
Sing-Fai Leung, Y M Dennis Lo, Anthony T C Chan, et al.
Clinical Chemistry
|
December 20, 2003
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody
Sing-Fai Leung, John S Tam, Anthony T C Chan, et al.
World Journal of Gastroenterology
|
January 21, 2006
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma
Terence C W Poon, Clarissa H S Chiu, Paul B S Lai, et al.
Cancer
|
July 9, 2004
Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group
Edwin P Hui, Sing F Leung, Joseph S K Au, et al.
Investigational New Drugs
|
September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
Brigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Cancer
|
September 19, 2002
A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma
Tony S K Mok, Herman Wong, Benny Zee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 14, 2004
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience
Michael K M Kam, Peter M L Teo, Ricky M C Chau, et al.
European Journal of Radiology
|
November 17, 2004
Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes
Ann D King, Gary M K Tse, Edmund H Y Yuen, et al.
Cancer Chemotherapy and Pharmacology
|
September 1, 2007
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy
Brigette Ma, Edwin P Hui, Ann King, et al.
Cancer
|
March 29, 2002
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients
Thomas W T Leung, Amanda M Y Tang, Benny Zee, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 70) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2003
Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2
Sing-Fai Leung, Y M Dennis Lo, Anthony T C Chan, et al.
Clinical Chemistry
|
December 20, 2003
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody
Sing-Fai Leung, John S Tam, Anthony T C Chan, et al.
World Journal of Gastroenterology
|
January 21, 2006
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma
Terence C W Poon, Clarissa H S Chiu, Paul B S Lai, et al.
Cancer
|
July 9, 2004
Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group
Edwin P Hui, Sing F Leung, Joseph S K Au, et al.
Investigational New Drugs
|
September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
Brigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Cancer
|
September 19, 2002
A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma
Tony S K Mok, Herman Wong, Benny Zee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 14, 2004
Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience
Michael K M Kam, Peter M L Teo, Ricky M C Chau, et al.
European Journal of Radiology
|
November 17, 2004
Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes
Ann D King, Gary M K Tse, Edmund H Y Yuen, et al.
Cancer Chemotherapy and Pharmacology
|
September 1, 2007
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy
Brigette Ma, Edwin P Hui, Ann King, et al.
Cancer
|
March 29, 2002
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients
Thomas W T Leung, Amanda M Y Tang, Benny Zee, et al.
Page
of 7